Logo 2021 MediumAsiaWorld-Expo
Hong Kong
Asset 2brandhk en scaled 2


Bring the world together to navigate and capitalize on the opportunities in HK; a burgeoning international biotech hub. One2One partnership intends to aid attendees in identifying and connecting prospective partners in the form of investors, analysts and partnering companies for future collaborations. Align your goals and maximize your returns with others investing in the future of biotech.
  • Networking opportunity with industry practitioners, academicians and delegates from reputable biopharma firms and educational institutions
  • Connect with prospective partners: investors, analysts or partnering companies to accelerate your developments for your next big breakthrough
  • Form valuable partnerships with leading biotech firms
  • Meet and greet with high-level executives
  • Build promising partnerships across the field

One2one Partnering process and steps:

One2OnePartnering Step1 Louvinia One2OnePartnering_Step2_Louvinia.png One2OnePartnering_Step3_Louvinia.png One2OnePartnering Step4 Louvinia One2OnePartnering Step5 Louvinia

BIOHK2021 exhibitors and conference attendees would be free to register the system now.
The matching system will open in the Mid November 2020.

If you have any questions, our team will be more than happy to help you plan your experience.
Please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

BIOHK2021 Convention Participating Companies

Adicon Clinical Laboratories Affix Capital AlphaSmart World Limited
AML Holdings Limited ASC Therapeutics, Inc. Asia Investment Fund Management Limited
Asian Fund for Cancer Research Limited Ausvic Capital Limited Cathay Capital
Center for Chinese Medicine R & D Chinese University of Hong Kong City University of Hong Kong
CW Data Technologies Deloitte eChinaHealth
European Federation of Biotechnology Finet Group Ltd Food and Environmental Hygiene, Food and Health Bureau, Government Secretariat HKSAR
Galaxy Treasure Group Global Bio & Investment Monthly Good Health Capital (New York)
Great Treasure International Greater Bay Area Biotech Alliance Guangdong Medical Valley (GDMV)
Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences Hai Kang Life Corporation Limited HKEX Group
Hong Kong Agriculture, Fisheries and Conservation Hong Kong Association of the Pharmaceuticals Industry Hong Kong Innovation and Technology Commission
Hong Kong Intellectual Property Department Hong Kong Science and Technology Park Hong Kong Tourism Board
Hong Kong Trade and Industry Department Hong Kong University of Science and Technology Incando Therapeutics
Institute of Chinese Medical Sciences, University of Macau International Iberian Nanotechnology Laboratory InvestHK
Koln 3D Technology (Medical) Limited Lee's Pharmaceutical Holdings Limited LiLaw Inc.
Lo Ka Chung Charitable Foundation Macau International Healthcare Think Tank Marathon Venture Partners
McKinsey & Company MGI Ming-Wai Lau Centre for Reparative Medicine, HK node, Karolinska Institutet (KI), Sweden.
National Institute of Metrology, China National Foundation for Cancer Research Pacific Life Assurance Co., Ltd.
Pan Asia Venture Development Platform (PAVD) Pangenia Inc and DiagCor Life Science Ltd. Portfolio Management and Research
Powder Pharmaceuticals Incorporated Queens (Shenzhen) Biotechnology Co., Ltd. Ryoden Medical Holdings Limited
SenseTime Hong Kong Serica Capital Shenzhen Association for Science and Technology
Shenzhen Govita Medical Laboratory Shenzhen International Institute for Biomedical Research SPARQ Capital
The Bayhelix Group The Chinese University of Hong Kong Torch High Technology Industry Development Center Ministry of Science and Technology
Winner Medical Group Wise Ally Holdings Ltd  WuXi AppTec Co., Ltd.